Amalgamated Financial Corp. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Amalgamated Financial Corp. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $104.45M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $106.43M | Mar 5, 2026 |
| FY2025 | Dec 31, 2023 | $87.98M | Mar 5, 2026 |
| FY2024 | Dec 31, 2022 | $81.48M | Mar 6, 2025 |
| FY2023 | Dec 31, 2021 | $52.94M | Mar 7, 2024 |
| FY2022 | Dec 31, 2020 | $46.19M | Mar 9, 2023 |
| FY2021 | Dec 31, 2019 | $47.20M | Mar 11, 2022 |
| FY2020 | Dec 31, 2018 | $44.65M | Mar 15, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $135.78M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $124.07M | Mar 5, 2026 |
| FY2025 | Dec 31, 2023 | $117.22M | Mar 5, 2026 |
| FY2024 | Dec 31, 2022 | $147.32M | Mar 6, 2025 |
| FY2023 | Dec 31, 2021 | $70.54M | Mar 7, 2024 |
| FY2022 | Dec 31, 2020 | $65.77M | Mar 9, 2023 |
| FY2021 | Dec 31, 2019 | $83.46M | Mar 11, 2022 |
| FY2020 | Dec 31, 2018 | $31.02M | Mar 15, 2021 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.38M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $1.78M | Mar 5, 2026 |
| FY2025 | Dec 31, 2023 | $1.48M | Mar 5, 2026 |
| FY2024 | Dec 31, 2022 | $1.67M | Mar 6, 2025 |
| FY2023 | Dec 31, 2021 | $2.40M | Mar 7, 2024 |
| FY2022 | Dec 31, 2020 | $1.61M | Mar 9, 2023 |
| FY2021 | Dec 31, 2019 | $753.0K | Mar 11, 2022 |
| FY2020 | Dec 31, 2018 | $1.43M | Mar 15, 2021 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.87B | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $8.26B | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | $7.97B | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $7.84B | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $7.08B | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $5.98B | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $5.33B | Mar 15, 2021 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.08B | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $7.55B | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | $7.39B | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $7.33B | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $6.51B | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $5.44B | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $4.83B | Mar 15, 2021 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $707.65M | Mar 6, 2025 |
| FY2024 | Dec 31, 2023 | $585.23M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $508.82M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $563.74M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $535.69M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $490.41M | Mar 15, 2021 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.94M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $12.94M | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | $12.94M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $12.94M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $12.94M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $12.94M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $12.94M | Mar 15, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $567.27M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $480.14M | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | $388.03M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $330.28M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $260.05M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $217.21M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $181.13M | Mar 15, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $291.22M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | $60.75M | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | $90.57M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $63.54M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $330.49M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | $38.77M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | $122.54M | Mar 15, 2021 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $0 | Mar 15, 2021 |
| FY2020 | Dec 31, 2019 | $75.00M | Mar 15, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Mar 5, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Mar 5, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Mar 6, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Mar 7, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Mar 15, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Mar 15, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Mar 15, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Mar 15, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Mar 15, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Mar 5, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Mar 5, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Mar 6, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Mar 7, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Mar 15, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Mar 15, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Mar 15, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Mar 15, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Mar 15, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 29.82M | Mar 5, 2026 |
| FY2025 | Dec 31, 2024 | 30.67M | Mar 5, 2026 |
| FY2024 | Dec 31, 2023 | 30.43M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | 30.70M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | 31.13M | Mar 9, 2023 |
| FY2021 | Dec 31, 2020 | 31.05M | Mar 11, 2022 |
| FY2020 | Dec 31, 2019 | 31.52M | Mar 15, 2021 |